Similarly, angiopoietin like protein 8 (ANGPTL8), the latest member of the ANGPTL family, is also regarded as a potential target for anti‐hyperlipidemia due to its ability to inhibit LPL activity by interacting with ANGPTL3, and then regulate plasma TG levels (Li et al., 2021; Sylvers‐Davie & Davies, 2021). The gene discussed is LPL; the disease is hyperlipidemia.